Marquette General Cancer Center
Breast
Study Name - SWOG S1007
Study
Description - A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or Less
IRB Open Date - 04/13/2011
Data Privacy Statement for Research Studies
Study Name - SCUSF 0806
Study
Description - Phase II placebo-controlled trial of Lisinopril and Coreg CR® to reduce cardiotoxicity in patients with breast cancer receiving (neo) adjuvant chemotherapy with Trastuzumab (Herceptin®).
IRB Open Date - 03/14/2011
Data Privacy Statement for Research Studies
Study Name - NSABP B-47
Study
Description - A Randomized Phase III Trial of Adjuvant Therapy comparing Chemotherapy Alone (Six cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer.
IRB Open Date - 03/04/2011
Data Privacy Statement for Research Studies
Study Name - NSABP B46-1
Study
Description - A Phase III Clinical Trial Comparing the Combination of TC
IRB Open Date - 01/13/2010
Data Privacy Statement for Research Studies
Study Name -NSABP PROTOCOL B-43
Study
Description -
IRB Open Date - 06-11-2008
Data Privacy Statement for Research Studies
|
|
|||